Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,821 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low starting-dosage of nintedanib for the reduction of early termination.
Ikeda S, Sekine A, Baba T, Katano T, Tabata E, Shintani R, Yamakawa H, Niwa T, Oda T, Okuda R, Kitamura H, Ogura T. Ikeda S, et al. Among authors: kitamura h. Respir Investig. 2019 May;57(3):282-285. doi: 10.1016/j.resinv.2018.12.010. Epub 2019 Feb 13. Respir Investig. 2019. PMID: 30772264 No abstract available.
Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis.
Ikeda S, Sekine A, Baba T, Katano T, Tabata E, Shintani R, Sadoyama S, Yamakawa H, Oda T, Okuda R, Kitamura H, Iwasawa T, Takemura T, Ogura T. Ikeda S, et al. Among authors: kitamura h. BMC Pulm Med. 2019 Apr 11;19(1):78. doi: 10.1186/s12890-019-0841-7. BMC Pulm Med. 2019. PMID: 30975118 Free PMC article.
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study.
Maher TM, Stowasser S, Nishioka Y, White ES, Cottin V, Noth I, Selman M, Rohr KB, Michael A, Ittrich C, Diefenbach C, Jenkins RG; INMARK trial investigators. Maher TM, et al. Lancet Respir Med. 2019 Sep;7(9):771-779. doi: 10.1016/S2213-2600(19)30255-3. Epub 2019 Jul 17. Lancet Respir Med. 2019. PMID: 31326319 Free article. Clinical Trial.
Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.
Okuda R, Hagiwara E, Katano T, Ikeda S, Sekine A, Kitamura H, Baba T, Okudela K, Ohashi K, Ogura T. Okuda R, et al. Among authors: kitamura h. Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(1):39-46. doi: 10.36141/svdld.v36i1.7117. Epub 2019 May 1. Sarcoidosis Vasc Diffuse Lung Dis. 2019. PMID: 32476935 Free PMC article.
Unilateral upper lung-field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis after thoracic surgery: Clinical and radiological courses with autopsy findings.
Sekine A, Satoh H, Takemura T, Matsumura M, Okudela K, Iwasawa T, Okabayashi H, Ikeda S, Yamakawa H, Oda T, Okuda R, Kitamura H, Baba T, Komatsu S, Hagiwara E, Ogura T. Sekine A, et al. Among authors: kitamura h. Respir Investig. 2020 Nov;58(6):448-456. doi: 10.1016/j.resinv.2020.05.001. Epub 2020 Jul 11. Respir Investig. 2020. PMID: 32660899
1,821 results